12/17/2025
Drug-induced hyperpigmentation is more common than many realize—accounting for up to 20% of acquired pigmentation cases. At the 2025 Pigmentary Disorders Exchange Symposium, Dr. Rebecca Vasquez delivered an expert walkthrough of how to recognize, diagnose, and differentiate these complex presentations from melasma or PIH.
From minocycline, antimalarials, and hydroquinone to less expected agents like silver and kratom, each drug leaves distinct clinical clues. Her key message: Not all hyperpigmentation is created equal. Recognizing drug-induced patterns leads to earlier diagnosis, better patient counseling, and more targeted management.
Read a Next Steps in Derm session summary: https://ow.ly/pgfk50XKvn7